A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

NCT01196078 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: erlotinib [Tarceva]
DRUG: vinorelbine

Sponsor

Hoffmann-La Roche